Hypertension care-cascade gaps and stroke burden from high systolic blood pressure
- 4 September 2026
- journal article
- Published by Oxford University Press (OUP) in European Journal of Preventive Cardiology
Abstract
Aims: Stroke remains a major global health challenge, with high systolic blood pressure (HSBP) a leading modifiable contributor. The hypertension care-cascade gap most strongly associated with HSBP-attributable stroke burden across countries remains unclear. Methods and results: This country-level ecological study used NCD Risk Factor Collaboration hypertension care-cascade estimates, Global Burden of Disease 2023 HSBP-attributable stroke estimates, and Socio-demographic Index (SDI) data, 1990–2019, including 199 countries/territories and 5970 country-years. Indicators were diagnosis, treatment, blood pressure control, and cumulative gaps; outcomes were HSBP-attributable stroke disability-adjusted life-year (DALY) and stroke death rates. Analyses included correlations, country-year models, sex-age-stratified models, exploratory 10-year age-shifted models, and 2019 country typology. By 2019, 80.2% of people with hypertension lacked blood pressure control. The blood pressure control gap aligned most clearly with HSBP-attributable stroke burden; each 10-percentage-point higher gap was associated with a 49.1% higher stroke DALY rate (95% CI 38.5–60.5) and a 47.7% higher stroke death rate (37.9–58.2), exceeding other gaps. Associations were consistent across sex-age strata. Priority analyses identified low-SDI older men as high-gap/high-burden strata, while exploratory age-shifted analyses showed the strongest aggregate associations in men aged 30–44 years and women aged 35–44 years at the index year. Conclusion: The control gap showed the strongest country-level alignment with HSBP-attributable stroke burden, with high-gap/high-burden patterns concentrated among older men in low-SDI settings. Exploratory age-shifted patterns in younger adults warrant further study. These findings highlight the potential value of the control gap for population-level surveillance and comparative assessment.Keywords
Funding Information
- Joint Funds for the Innovation of Science and Technology of Fujian Province (2023Y9339)
- Fujian Provincial Health Technology Project (2023CXA006)
- Natural Science Foundation of Fujian Province (2025J01497)
This publication has 50 references indexed in Scilit:
- Global pattern, trend, and cross-country inequality of cardiovascular diseases caused by hypertension from 1990 to 2021, with projection from 2022 to 2060American Journal of Preventive Cardiology, 2025
- Hypertension-attributable stroke burden in younger vs older people: analysis of GBD 2021 and NHANES databasesAmerican Journal of Preventive Cardiology, 2025
- Temporal trends in cross-country inequalities of stroke and subtypes burden from 1990 to 2021: a secondary analysis of the global burden of disease study 2021eClinicalMedicine, 2024
- Community-Based Participatory Research and System Dynamics Modeling for Improving Retention in Hypertension CareJAMA Network Open, 2024
- The care cascade of chronic obstructive pulmonary disease in China: a cross-sectional study of individual-level data at enrolment into the national ‘Happy Breathing’ ProgrammeeClinicalMedicine, 2024
- Evaluating the hypertension care cascade in middle-aged and older adults in The Gambia: findings from a nationwide surveyeClinicalMedicine, 2023
- Population attributable fraction of hypertension for dementia: global, regional, and national estimates for 186 countrieseClinicalMedicine, 2023
- Harmonization of the American College of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood Pressure/Hypertension GuidelinesJACC, 2022
- Blood Pressure Trajectories and Outcomes for Veterans Presenting at VA Medical Centers with a Stroke or Transient Ischemic AttackThe American Journal of Medicine, 2022
- Long-term trends of BMI and cardiometabolic risk factors among adults with type 1 diabetes: An observational study from the German/Austrian DPV registryDiabetes Research and Clinical Practice, 2021